Clinical and economic efficiency to reduce dose etanercept and adalimumab in patients with rheumatoid arthritis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Clinical and economic efficiency to reduce dose etanercept and adalimumab in patients with rheumatoid arthritis ; volume:10 ; number:3 ; day:28 ; month:11 ; year:2012 ; pages:1-2 ; date:11.2012
Journal of translational medicine ; 10, Heft 3 (28.11.2012), 1-2, 11.2012
- Creator
-
Martínez-Pérez, Rosalia
- Contributor
-
Rodríguez-Montero, Sergio
Muñoz, Alejandro
Uceda, Julia
León, Mario
Gallo, Francisco
Velloso, Maria Luisa
Marenco, Jose Luis
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-10-S3-P51
- URN
-
urn:nbn:de:1111-2016041443468
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Martínez-Pérez, Rosalia
- Rodríguez-Montero, Sergio
- Muñoz, Alejandro
- Uceda, Julia
- León, Mario
- Gallo, Francisco
- Velloso, Maria Luisa
- Marenco, Jose Luis
- SpringerLink (Online service)
Other Objects (12)
Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
Juvenile idiopathische Arthritis – Langzeitsicherheit von Etanercept und Adalimumab
Single-Arm Study of Etanercept in Adult Patients with Moderate to Severe Rheumatoid Arthritis Who Failed Adalimumab Treatment
Satisfaction with Subcutaneous Golimumab and its Auto-Injector among Rheumatoid Arthritis Patients with Inadequate Response to Adalimumab or Etanercept
Cost-consequence analysis of tocilizumab versus adalimumab and etanercept among rheumatoid arthritis patients in Saudi Arabia: a single-center study
Cost-effectiveness of adalimumab for rheumatoid arthritis in Germany
Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis
Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis
Etanercept may induce neurosarcoidosis in a patient treated for rheumatoid arthritis
Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis
Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis
Etanercept und Adalimumab: wirksam und sicher bei Kleinkindern mit JIA
Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
Juvenile idiopathische Arthritis – Langzeitsicherheit von Etanercept und Adalimumab
Single-Arm Study of Etanercept in Adult Patients with Moderate to Severe Rheumatoid Arthritis Who Failed Adalimumab Treatment
Satisfaction with Subcutaneous Golimumab and its Auto-Injector among Rheumatoid Arthritis Patients with Inadequate Response to Adalimumab or Etanercept
Cost-consequence analysis of tocilizumab versus adalimumab and etanercept among rheumatoid arthritis patients in Saudi Arabia: a single-center study
Cost-effectiveness of adalimumab for rheumatoid arthritis in Germany
Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis
Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis
Etanercept may induce neurosarcoidosis in a patient treated for rheumatoid arthritis
Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis
Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis
Etanercept und Adalimumab: wirksam und sicher bei Kleinkindern mit JIA
Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
Juvenile idiopathische Arthritis – Langzeitsicherheit von Etanercept und Adalimumab
Single-Arm Study of Etanercept in Adult Patients with Moderate to Severe Rheumatoid Arthritis Who Failed Adalimumab Treatment
Satisfaction with Subcutaneous Golimumab and its Auto-Injector among Rheumatoid Arthritis Patients with Inadequate Response to Adalimumab or Etanercept
Cost-consequence analysis of tocilizumab versus adalimumab and etanercept among rheumatoid arthritis patients in Saudi Arabia: a single-center study
Cost-effectiveness of adalimumab for rheumatoid arthritis in Germany
Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis
Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis
Etanercept may induce neurosarcoidosis in a patient treated for rheumatoid arthritis
Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis
Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis